These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20222854)

  • 1. Natural products in structure-assisted design of molecular cancer therapeutics.
    Pfisterer PH; Wolber G; Efferth T; Rollinger JM; Stuppner H
    Curr Pharm Des; 2010 May; 16(15):1718-41. PubMed ID: 20222854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ready for a comeback of natural products in oncology.
    Bailly C
    Biochem Pharmacol; 2009 May; 77(9):1447-57. PubMed ID: 19161987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.
    Franke J; Eichner S; Zeilinger C; Kirschning A
    Nat Prod Rep; 2013 Oct; 30(10):1299-323. PubMed ID: 23934201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current impact of natural products in the discovery of anticancer drugs].
    Monneret C
    Ann Pharm Fr; 2010 Jul; 68(4):218-32. PubMed ID: 20637355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of natural products derivatization method in the design of targeted anticancer agents from 2000 to 2018.
    Liu W; Li Q; Hu J; Wang H; Xu F; Bian Q
    Bioorg Med Chem; 2019 Dec; 27(23):115150. PubMed ID: 31635893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural product inhibitors of Hsp90: potential leads for drug discovery.
    Amolins MW; Blagg BS
    Mini Rev Med Chem; 2009 Feb; 9(2):140-52. PubMed ID: 19200020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent studies on natural products as anticancer agents.
    Ravelo AG; Estévez-Braun A; Chávez-Orellana H; Pérez-Sacau E; Mesa-Siverio D
    Curr Top Med Chem; 2004; 4(2):241-65. PubMed ID: 14754457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP90: a rising star on the horizon of anticancer targets.
    Dai C; Whitesell L
    Future Oncol; 2005 Aug; 1(4):529-40. PubMed ID: 16556029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazoline containing natural products as anticancer agents: a review.
    Kaur K; Kumar V; Sharma AK; Gupta GK
    Eur J Med Chem; 2014 Apr; 77():121-33. PubMed ID: 24631731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?
    Khandelwal A; Crowley VM; Blagg BSJ
    Med Res Rev; 2016 Jan; 36(1):92-118. PubMed ID: 26010985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention.
    Narayanankutty V; Narayanankutty A; Nair A
    Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial; Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery - Part II.
    Scotti L; Scotti MT
    Curr Protein Pept Sci; 2018 Feb; 19(4):342. PubMed ID: 29493446
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational approaches to natural-product-based drug design.
    Haustedt LO; Mang C; Siems K; Schiewe H
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
    Kumar D; Jain SK
    Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent Necroptosis.
    Li D; Li C; Li L; Chen S; Wang L; Li Q; Wang X; Lei X; Shen Z
    Cell Chem Biol; 2016 Feb; 23(2):257-266. PubMed ID: 27028885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine-scaffold Hsp90 inhibitors.
    Chiosis G; Tao H
    IDrugs; 2006 Nov; 9(11):778-82. PubMed ID: 17096299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Simplification of Natural Products.
    Wang S; Dong G; Sheng C
    Chem Rev; 2019 Mar; 119(6):4180-4220. PubMed ID: 30730700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.